Impact factor: 0.877
ISSN Print: 0731-8898
You have access to:Volume 34, 2015 Volume 33, 2014 Volume 32, 2013 Volume 31, 2012 Volume 30, 2011 Volume 29, 2010 Volume 28, 2009 Volume 27, 2008 Volume 26, 2007 Volume 25, 2006 Volume 24, 2005 Volume 23, 2004 Volume 22, 2003 Volume 21, 2002 Volume 20, 2001
Journal of Environmental Pathology, Toxicology and Oncology
Hesperidin Protects Renal and Hepatic Tissues Against Free Radical-Mediated Oxidative Stress During DMBA-Induced Experimental Breast Cancer
Department of Pharmacology and Environmental Toxicology, Dr. A. L. Mudhaliar Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, Tamilnadu, India
Maruthaiveeran Periyasamy Balasubramanian
Department of Pharmacology and Environmental Toxicology, Dr.ALM.Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, Tamilnadu, India.
Hesperidin has been reported to have an excellent and wide variety of biological activities. This property has brought the compound to a new stage in the treatment of various oxidative stress-mediated diseases. The present investigation was aimed to evaluate the therapeutic potential of hesperidin by assaying the activities of antioxidant enzymes, lipid peroxidation, membrane bound marker enzymes, adenosine triphosphates, and TCA cycle enzymes, especially in kidney tissues during 7,12-dimethybenz(a)anthracene-induced breast cancer. Daily oral administration of hesperidin (30 mg/kg body wt) to breast cancer-bearing rats for 45 days demonstrated a significant (P < .05) decline in renal lipid peroxidation and membrane bound marker enzymes, as well as a remarkable increase in adenosine triphosphatases, mitochondrial functional enzymes, and renal antioxidants. Furthermore, histological studies of liver and kidney provided evidence of biochemical alterations. Thus, the protective effects of hesperidin on attenuating the peroxidation reaction and membrane bound marker enzyme activities as well as upregulation of adenosine triphosphatases, TCA cycle enzymes, and antioxidants suggest promising uses of flavonoglycoside hesperidin in the future treatment of oxidative stress-mediated diseases.
Keywords: marker enzymes, kidney, antioxidants, LPO, ATPase, mitochondrial enzymes, hesperidin, DMBA, breast cancer
|Home||Begell Digital Library||eBooks||Journals||References & Proceedings||Research Collections|